Literature DB >> 3310943

Atypical pulmonary and neurologic complications of amiodarone in the same patient. Report of a case and review of the literature.

A S Manolis1, T Tordjman, K D Mack, N A Estes.   

Abstract

Atypical manifestations of pulmonary toxicity and previously unreported autonomic nervous system dysfunction complicating amiodarone therapy were observed in a patient being treated for sustained ventricular tachycardia. Pulmonary and hepatic nodules on computed tomographic scan masquerading as metastatic carcinoma were initially noted. Focal infiltrates and a large left pleural effusion mimicking infection, malignant neoplasm, or collagen vascular disease became manifest at a later stage. Autonomic dysfunction presented as incapacitating orthostatic hypotension and persisted for six weeks after amiodarone withdrawal. The pleuropulmonary toxic effects were reversible on discontinuation of amiodarone therapy, and resolution was hastened by short-course steroid treatment.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3310943

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  4 in total

1.  Amiodarone toxicity presenting as pulmonary mass and peripheral neuropathy: the continuing diagnostic challenge.

Authors:  I Azzam; N Tov; N Elias; J E Naschitz
Journal:  Postgrad Med J       Date:  2006-01       Impact factor: 2.401

Review 2.  The clinical spectrum of amiodarone-associated optic neuropathy.

Authors:  Lenworth N Johnson; Gregory B Krohel; Eric R Thomas
Journal:  J Natl Med Assoc       Date:  2004-11       Impact factor: 1.798

3.  Orthostatic Hypotension in Patients With Left Ventricular Assist Devices: Acquired Autonomic Dysfunction.

Authors:  Marat Fudim; Joseph G Rogers; Camille Frazier-Mills; Chetan B Patel
Journal:  ASAIO J       Date:  2018 May/Jun       Impact factor: 2.872

Review 4.  COVID-19 infection and cardiac arrhythmias.

Authors:  Antonis S Manolis; Antonis A Manolis; Theodora A Manolis; Evdoxia J Apostolopoulos; Despoina Papatheou; Helen Melita
Journal:  Trends Cardiovasc Med       Date:  2020-08-16       Impact factor: 6.677

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.